You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《滬深兩市》上證3,500點遇阻收跌 創板跌2.8% 內險股逆市揚 寧德時代續跌逾半成
內地昨日(10日)新增本土確診病例56例。人行今日(11日)進行200億人民幣(下同)7天期逆回購操作,利率持平。1月新增貸款和社融增量雙雙創歷史新高。人民幣兌美元中間價今下調82點。上證、深成、創板低開後早市個別發展,銀行及保險股帶動上證曾上3,500點後遇阻回軟,創板低開低走,午後跌幅擴大至近3%。 上證高低見3,500/3,459,全日反覆跌22點或0.7%,近低收報3,462點;深成指跌207點或1.6%,收報13,224點;創業板指數跌80點或2.8%,近低收報2,746點,成交2,109億元。上證深成全日成交分別為4,263億元及5,652.5億元。 中資金融股表現向好,工行(601398.SH)及建行(601939.SH)分別升0.2%及0.6%。內險股逆市上揚,中國平安(601318.SH)及國壽(601628.SH)分別揚2.6%及7.3%。太保(601601.SH)升3.4%。 傳內地大型AMC開始參與風險房企重組,地產股個別發展,萬科A(000002.SZ)升1.6%。金地集團(600383.SH)跌0.8%。保利發展(600048.SH)1月簽約金額接年減少34.29%,股價跌1.7%。 近期強勢的中移動(00941.HK)斥逾4億元回購H股股份,中移動A股(600941.SH)股價反覆升0.9%。 昨日受壓的寧德時代(300750.SZ)及比亞迪(002594.SZ)分別續跌5.4%及4.1%。 受藥明生物(02269.HK)兩家子公司被美國商務部列入UVL事件影響,藥明康德A股(603259.SH)連跌多日,藥明康德發公告稱,公司目前生產經營正常,經營情況未發生重大變化,股價續跌3.3%。(ta/a) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account